"We identified a novel candidate oncogenic DOCK5 variant confirmed using qRT-PCR in a separate primary tumor validation set. Loss- and gain-of-function experiments indicated that DOCK5 variant promoted proliferation migration and invasion of HPV-negative HNSCC cells and patients with higher expression of DOCK5 variant showed decreased overall survival."xsd:string